We describe a 24-year-old man with type 1 diabetes mellitus and a cavitary lesion in the right upper lobe, caused by a zygomycete. Surgical resection plus liposomal amphotericin B therapy was successful. We discuss predisposing condition, clinical findings, diagnosis, and treatment of pulmonary zygomycosis.
KontoyiannisDP, LewisRE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am, 2006; 20(3):581–607.
3.
KontoyiannisDP, LionakisMS, LewisRE, ChamilosG, HealyM, PeregoC, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis, 2005; 191(8):1350–1360.
4.
ChakrabartiA, DasA, SharmaA, PandaN, DasS, GuptaKL, et al. Ten years' experience in Zygomycosis at a tertiary care center in India. J Infect, 2001; 42(4):261–266.
5.
LakhkarBN, RajagopalKV. Mucormycosis - a rare cause of multiple pulmonary nodules. Indian J Radiol Imaging, 2002; 12(3):446.
6.
Van CampenhoutA, Van CampenhoutC, LagrouAR, Manuel-Y-KeenoyB. Effects of in vitro glycation on Fe3+ binding and Fe3tiso forms of transferrin. Clin Chem, 2004; 50(9):1640–1649.
LeeFY, MossadSB, AdalKA. Pulmonary mucomycosis- the last 30 years. Arch Intern Med, 1999; 159(12):1301–1309.
9.
TedderM, SprattJA, AnstadtMP, HegdeSS, TedderSD, LoweJE. Pulmonary Zygomycosis: results of medical and surgical therapy. Ann Thorac Surg, 1994; 57(4):1044–1050.
10.
FeraMT, La CameraE, De SarroA. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev Anti Infect Ther, 2009; 7(8):981–998.
11.
TragiannidisA, GrollAH. Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis. Clin Microbiol Infect, 2009; 15(Suppl 5):82–86.
